Back to Search
MAUREEN D MAYES M.D.
M.D.
Rheumatology Physician
NPI: 1255364238IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
L4562(TX)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
L4562(TX)
Education
EASTERN VIRGINIA MEDICAL SCHOOL
Class of 1976
Research & Publications (20)
Lack of evidence for bacterial infections in skin in patients with systemic sclerosis.
PMID 19402205·Am J Med Sci·2009
8-other
Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
PMID 14872498·Arthritis Rheum·2004
3-trial
Endothelin and endothelin receptor antagonists in systemic rheumatic disease.
PMID 12746891·Arthritis Rheum·2003
6-review
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.
PMID 12905479·Arthritis Rheum·2003
8-other
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.
PMID 19596691·Ann Rheum Dis·2010
4-observational
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
PMID 19333948·Arthritis Rheum·2009
3-trial
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
PMID 19248104·Arthritis Rheum·2009
4-observational
Gastric slow waves, gastrointestinal symptoms and peptides in systemic sclerosis patients.
PMID 19566588·Neurogastroenterol Motil·2009
8-other
Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.
PMID 18645136·Arch Dermatol·2008
2-rct
Development of a provisional core set of response measures for clinical trials of systemic sclerosis.
PMID 17893248·Ann Rheum Dis·2008
8-other
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.
PMID 18163481·Arthritis Rheum·2008
8-other
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
PMID 18438905·Arthritis Rheum·2008
4-observational
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
PMID 18512816·Arthritis Rheum·2008
4-observational
Disease and symptom burden in systemic sclerosis: a patient perspective.
PMID 17611983·J Rheumatol·2007
8-other
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis.
PMID 17522098·Rheumatology (Oxford)·2007
4-observational
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.
PMID 17717203·Am J Respir Crit Care Med·2007
4-observational
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
PMID 17469162·Arthritis Rheum·2007
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6410 FANNIN ST, 600
HOUSTON, TX 77030 - Phone
- (832) 325-7191
Quick Facts
- NPI
- 1255364238
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile